Men who took 400 international units of vitamin E daily had more prostate cancers compared to men who took a placebo. The findings showed that, per 1,000 men, there were 76 prostate cancers in men who took only vitamin E supplements, vs. 65 in men on placebo over a seven-year period, or 11 more cases per 1,000 men. This represents a 17 percent increase in prostate cancers relative to those who took a placebo.
MASSDEVICE ON CALL — Health care providers now have their own section of the successful AppStore, called "Apps for Healthcare Professionals," currently includes 49 apps for iPhone users and 52 for iPad.
The new section includes six categories for doctors to choose from: reference apps, educational apps, EMR & parient monitoring apps, imaging apps, point of care apps and personal care apps, and about a dozen of the apps are for consumer use.
MASSDEVICE ON CALL — Dr. Bernadine Healy, the first woman to lead the National Institutes of Health and the first physician to lead the American Red Cross died from recurring brain cancer died over the weekend.
She battled brain cancer for 13 years before passing away at her home in Gates Mills, Ohio on Saturday. She was 67 years old.
Pacemakers: Light-controlled cardiac assistance
Ohio State University researchers have received a $1.1 million federal grant to study the differences in outcomes in patients who have undergone total knee replacement operations.
The research will explore potential causes for the gap between some knee replacement patients who struggle to perform daily tasks, such as climbing the stairs, and other patients who are able to resume activities like hiking and tennis after their operations, according to a statement from Ohio State.
Personalized medicine firm MDxHealth SA (BSE:MDXH.BR) and its research partner NovioGendix B.V. won a $1.1 million grant to support the research and development of a new bladder cancer diagnostic.
The funding came from Eurotrans-Bio, a European Commission initiative that supports biotech R&D between companies and academia.
The National Institutes of Health and the Food & Drug Administration will dole out $9.4 million over three years to support a quartet of research projects in so-called "regulatory science."
The program is aimed at improving data for scientists and regulatory reviewers on medical device safety and at improving the "evaluation and availability of new medical products to the community," according to a press release.
The National Institutes of Health proposed new conflict-of-interest rules today that will do nothing to limit financial ties between government-funded researchers and private industry and leaves university administrators in charge of policing the arrangements.
The Food & Drug Administration and the National Institutes of Health launched a new program aimed at speeding innovative medical technologies to market.
The joint program involves translational science, “the shaping of basic scientific discoveries into treatments,” and regulatory science, or “the development and use of new tools, standards and approaches to more efficiently develop products and to more effectively evaluate product safety, efficacy and quality,” according to a press release.
By Merrill Goozner
While liberals go ballistic over President Obama’s call for budgetary freeze on discretionary domestic programs, Jared Bernstein, the former Economic Policy Institute economist heading up Vice President Joe Biden’s economics team, points out an overlooked fact in his surprise posting on The Huffington Post: there’s a lot of waste in the federal budget that a freeze can be useful in reallocating. You could create a lot more jobs and social benefit by cutting agricultural subsidies and shifting those dollars to mass transit projects under the rubric of a budget freeze.